Loss of noradrenergic function also leads directly to loss of synaptic plasticity and reduced neuronal health, for instance, due to loss of NGF/BDNF, which exacerbates AD neural toxicity (Follesa and Mocchetti, 1993; Marien et al., 2004) in areas such as the hippocampus. This evidence concerns the gene NGF and Alzheimer disease.